Skip to content

A Clinical Trial to Study the Effects of an Ayurvedic Ghrita Formulation, Mashadi Ghrita in the Patients of Ksheena Shukra

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF MASHADI GHRITA IN KSHEENA SHUKRA (OLIGOSPERMIA) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066599
Enrollment
30
Registered
2024-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

None listed

Sponsors

Dr Vikrant
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who fulfill the diagnostic criteria. Patients from any religion, occupation, or socio-economic class. Patients are willing to participate in the study and ready to sign the informed consent form.

Exclusion criteria

Exclusion criteria: Male patients with absolute Azoospermia and Teratozoospermia. Male patients on certain medications like antineoplastic agents (e.g., Nitrogen mustard, procarbazine, vincristine, methotrexate), cimetidine, estrogen and methyltestosterone. Patients have chromosomal disorders like Klinefelter’s syndrome. Patients suffering from major systemic disorders like Tuberculosis, AIDS and sexual Transmitted Diseases (STD) and other gonadal disorders like Testicular Atrophy, Testicular Failure and orchitis, which may interfere with study, will be excluded. Patients having any anatomical deformity in gonads (e.g., Cryptorchidism, Monorchidism)

Design outcomes

Primary

MeasureTime frame
After the treatment period, the following symptoms will be checked. Volume Color Concentration pH Viscosity Liquefaction Time Sperm Morphology Vitality Motility Seminal Fructose Sperm CountTimepoint: After 60 days

Secondary

MeasureTime frame
After the treatment period, the following symptoms will be checked. Desire Orgasm Rigidity Erection Ejaculation Post Act ExhaustionTimepoint: On 0th, 31st & 61st days

Countries

India

Contacts

Public ContactDr Vikrant

Alvas Ayurveda Medical College

shettysusheel13@gmail.com9980431676

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026